Vasopressin Offers No Survival Benefit for Septic Shock, University of British Columbia Study

VANCOUVER, British Columbia, Feb. 27 -- Low-dose vasopressin does not reduce septic shock mortality when used as an adjunct to conventional catecholamine vasopressors, according to a randomized controlled trial. (Feb. 28, New England Journal of Medicine)